ACL — Australian Clinical Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual balance sheet for Australian Clinical Labs, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2020 June 30th	R2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	35.3	36.3	27.5	20.6	26.8
Net Total Accounts Receivable
Net Total Receivables	63.3	63	91.1	75	81.4
Total Inventory
Prepaid Expenses
Total Current Assets	112	117	143	116	134
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	194	238	310	288	282
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	366	484	628	579	593
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	135	166	225	188	208
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	297	402	396	406	416
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	69	81.9	232	172	178
Total Liabilities & Shareholders' Equity	366	484	628	579	593
Total Common Shares Outstanding